Compare Medtronic PLC (MDT) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Palo Alto Networks Inc — how do they compare? Medtronic PLC trades at $89.21 (market cap $116.07B), while Palo Alto Networks Inc trades at $384.45 (market cap $312.80B). The key difference: Palo Alto Networks Inc is far larger — about 2.7× Medtronic PLC's market cap, and Medtronic PLC pays a 3.18% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals.
| MDT | PANW | |
|---|---|---|
Market Cap | $116.07B | $312.80B |
Sector | Health | Technology |
52-Week High | $105.35 | $385.04 |
52-Week Low | $73.75 | $141.67 |
Enterprise Value | $134.82B | $311.76B |
Dividend Yield | 3.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $89.41, up 2.58% on the day, reflecting positive momentum. The stock exhibits bullish technical signals with strong moving average support and a consensus analyst price target of $98.75. Fundamentally, the company reported revenue of $33.54B for 2025 with a net income margin of 13.2%, and has consistently beaten EPS estimates in recent quarters. Recent news highlights institutional acquisitions and positive developments in medical technology platforms.
The outlook for MDT is positive, driven by earnings beats, robust cash flow, and growth in cardiac and robotic surgery segments. Key opportunities include undervaluation relative to analyst targets and dividend stability. Risks involve rising debt levels and competitive pressures in the medtech sector. The stock presents a compelling case for growth-oriented income investors.
Palo Alto Networks (PANW) trades at $385.04, up 5.82% over the past day, reflecting strong momentum amid positive sentiment around AI-driven cybersecurity demand. The stock exhibits a bullish technical setup with moving averages supporting the uptrend, while RSI levels suggest potential overbought conditions. Fundamentally, the company reported revenue of $9.22B in 2025 with a net income margin of 7.95%, though valuation ratios like P/E of 333.74 indicate a premium. Recent news highlights record highs following the Black Hat conference and AI platform launches, though a Chinese regulatory review introduces near-term uncertainty.
The outlook for PANW remains positive given robust revenue growth, AI integration, and Wall Street's bullish consensus, but risks include elevated valuation, integration costs from acquisitions, and geopolitical scrutiny. Investors should weigh the company's leadership in cybersecurity against potential volatility from regulatory developments and high expectations priced into the stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
